Is Zenas BioPharma, Inc. (ZBIO) a Buy, Sell, or Hold?
NASDAQ : ZBIO
Zenas BioPharma, Inc. — Competitors
$32.72 USD
$2.33 (7.67%)
- Volume
- 338.5K
- Average Volume
- 786.82K
- Market Capitalization
- $2.07B
- P/E Ratio
- -3.60
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $44.60
- Year Low
- $13.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.94
ZBIO vs. The Competition
| Properties | ZBIO | AMLX | INBX | NTLA |
|---|---|---|---|---|
| Market Cap | $2.07B | $2.11B | $1.23B | $1.22B |
| Shares Outstanding | $63.13M | $111.19M | $14.67M | $112.21M |
| P/E Ratio | -3.6 | -12.85 | -9.99 | -3.07 |
| EPS | -7.64 | -1.36 | -8.35 | -3.33 |
| Day Low | 30.855 | 18.485 | 82.3 | 10.63 |
| Day High | 33.3 | 19.375 | 85.85 | 11.31 |
| Year Low | 13.5 | 7.48 | 20.55 | 7.95 |
| Year High | 44.6 | 19.35 | 155.29 | 28.25 |
| Average Price 50 | 22.7944 | 15.7679 | 96.2965 | 13.91 |
| Average Price 200 | 25.57325 | 14.6848 | 82.5968 | 13.40318 |
| Volume | 338.5K | 963.19K | 61653.53 | 1.15M |
| Average Volume | - | - | - | - |